Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis

Cellular and Molecular Immunology

Volumn 8, Issue 6, 2011, Pages 469-478

  Chen, Da P ^a,b   Wong, Chun K ^a   Tam, Lai S ^a   Li, Edmund K ^a   Lam, Christopher W K ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

cytokines; fibroblast like synoviocytes; rheumatoid arthritis; signal transduction; uric acid

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; URATE;

ARTICLE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

EID: 80755143464     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2011.35     Document Type: Article

References (50)

1. VanItallie TB. Gout: epitome of painful arthritis. Metabolism 2010; 59: S32-S36.
2. McCormack WJ, Parker AE, O'Neill LA. Toll-like receptors and NOD-like receptors in rheumatic diseases. Arthritis Res Ther 243.2009; 11: 243.
3. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440. (Pubitemid 26130190)
4. Kuo CF, Tsai WP, Liou LB. Rare copresent rheumatoid arthritis and gout: comparison with pure rheumatoid arthritis andaliterature review. Clin Rheumatol 2008; 27: 231-235.
5. Abdullah S, Scott K, Featherstone T, Coady D. Pus, pannus or tophus: coexistent rheumatoid arthritis and gout. J Clin Rheumatol 2010; 16: 98.
6. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 2005; 115: 118-128. (Pubitemid 40693079)
7. Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 2002; 61: 975-980. (Pubitemid 35221685)
8. Jones DH, Kong YY, Penninger JM. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 2002; 61: 32-39.
9. Noss EH, Brenner MB. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 2008; 223: 252-270. (Pubitemid 351986192)
10. Bradley K, Scatizzi JC, Fiore S, Shamiyeh E, Koch AE, Firestein GS et al. Retinoblastoma suppression of matrix metalloproteinase-1, but not interleukin-6, though a p-38-dependent pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2004; 50: 78-87. (Pubitemid 38084290)
11. Wong CK, Chen DP, Tam LS, Li EK, Yin YB, Lam CW. Effects of inflammatory cytokine IL-27 onthe activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010; 12: R129
12. Ding B, Padyukov L, Lundström E, Seielstad M, Plenge RM, Oksenberg JR et al. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 2009; 60: 30-38.
13. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-621. (Pubitemid 43209108)
14. Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med 2008; 29: 290-308.
15. Shi Y, Mucsi AD, Ng G. Monosodium urate crystals in inflammation and immunity. Immunol Rev 2010; 233: 203-217.
16. Behrens MD, Wagner WM, Krco CJ, Erskine CL, Kalli KR, Krempski J et al. The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity. Blood 2008; 111: 1472-1479. (Pubitemid 351213435)
17. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521. (Pubitemid 37237047)
18. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241. (Pubitemid 43372104)
19. Gasse P, Riteau N, Charron S, Girre S, Fick L, PétrilliVet al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med 2009; 179: 903-913.
20. Inokuchi T, Ka T, Yamamoto A, Moriwaki Y, Takahashi S, Tsutsumi Z et al. Effects of ethanol on monosodium urate crystal-induced inflammation. Cytokine 2008; 42: 198-204.
21. Akahoshi T, Namai R, Murakami Y, Watanabe M, Matsui T, Nishimura A et al. Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum 2003; 48: 231-239. (Pubitemid 36091668)
22. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17F and IL-23: implications for Th17 lymphocyte-mediated allergic inflammation. J Immunol 2008; 180: 5625-5635.
23. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008; 118: 3537-3545.
24. Ip WK, Wong CK, Li ML, Li PW, Cheung PF, Lam CW. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response. Immunology 2007; 122: 532-541. (Pubitemid 350075949)
25. Bartok B, Firestein GS. Fibroblast-like synoviocytes. Key effector cells in rheumatoid arthritis. Immunol Rev 2010; 233: 233-255.
26. Akahoshi T, Murakami Y, Kitasato H. Recent advances in crystal-induced acute inflammation. Curr Opin Rheumatol 2007; 19: 146-150. (Pubitemid 46208772)
27. Webb R, Jeffries M, Sawalha AH. Uric acid directly promotes human T-cell activation. Am J Med Sci 2009; 337: 23-27.
28. Guerne PA, Terkeltaub R, Zuraw B, Lotz M. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989; 32: 1443-1452. (Pubitemid 20003912)
29. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010; 40: 1830-1835.
30. Schaible HG, von Banchet GS, Boettger MK, Bräuer R, Gajda M, Richter F et al. The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann NY Acad Sci 2010; 1193: 60-69.
31. Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood 2008; 112: 3959-3964.
32. Kobayashi T, Kouzaki H, Kita H. Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J Immunol 2010; 184: 6350-6358.
33. Martin WJ, Grainger R, Harrison A, Harper JL. Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival. J Rheumatol 2010; 37: 1228-1235.
34. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995; 17: 103-108.
35. Szekanecz Z, Szücs G, Szántó S, Koch AE. Chemokines in rheumatic diseases. Curr Drug Targets 2006; 7: 91-102.
36. Endo H, Akahoshi T, Nishimura A, Tonegawa M, Takagishi K, Kashiwazaki S et al. Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints. Clin Exp Immunol 1994; 96: 31-35. (Pubitemid 24213793)
37. Nishimura A, Akahoshi T, Takahashi M, Takagishi K, Itoman M, Kondo H et al. Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8. J Leukoc Biol 1997; 62: 444-449. (Pubitemid 27459772)
38. di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991; 87: 1375-1381.
39. Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY et al. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 2007; 108: 121-128.
40. Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH. The clinical significance of gelatinase B in gouty arthritis of the knee. Clin Chim Acta 2004; 339: 77-83.
41. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999; 58: 691-697. (Pubitemid 29517255)
42. Aicher WK, Heer AH, Trabandt A, Bridges SL Jr, Schroeder HW Jr, Stransky G et al. Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol 1994; 152: 5940-5948. (Pubitemid 24174176)
43. Han Z, Boyle DL, Aupperle KR, Bennett B, Manning AM, Firestein GS. Jun N-terminal kinase in rheumatoid arthritis. J Pharmacol Exp Ther 1999; 291: 124-130. (Pubitemid 29451581)
44. Perlman H, Georganas C, Pagliari LJ, Koch AE, Haines K3rd, Pope RM. Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 2000; 164: 5227-5235. (Pubitemid 30305200)
45. Cheng TH, Lin JW, Chao HH, Chen YL, Chen CH, Chan P et al. Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. Int J Cardiol 2010; 139: 42-49.
46. Pillinger MH, Dinsell V, Apsel B, Tolani SN, Marjanovic N, Chan ES et al. Regulation of metalloproteinases and NF-kappaB activation in rabbit synovial fibroblasts via E prostaglandins and Erk: contrasting effects of nabumetone and 6MNA. Br J Pharmacol 2004; 142: 973-982. (Pubitemid 39037047)
47. Schindler JF, Monahan JB, Smith WG. p38 pathway kinases as anti-inflammatory drug targets. J Dent Res 2007; 86: 800-811.
48. Volin MV, Huynh N, Klosowska K, Chong KK, Woods JM. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt. Arthritis Rheum 2007; 56: 2512-2522. (Pubitemid 47237270)
49. Filer A, Bik M, Parsonage GN, Fitton J, Trebilcock E, Howlett K et al. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheum 2009; 60: 1604-1614.
50. O'Neill LA. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov 2006; 5: 549-563. (Pubitemid 43971190)